Everything below concerns anti-doping. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a metabolic modulator. |
| Approved medical use | None in major jurisdictions | Not a registered drug. |
| Common test matrix | Urine | Most anti-doping samples use urine. |
| Typical detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Reference standard storage | -20 °C, desiccated | Typical for analytical standards. |
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Rhodium is a fission product of uranium-235: each kilogram of fission product contains a significant amount of the lighter platinum group metals. Used nuclear fuel is therefore a potential source of rhodium, but the extraction is complex and expensive, and the presence of rhodium radioisotopes requires a period of cooling storage for multiple half-lives of the longest-lived isotope (101Rh with a half-life of 3.3 years, and 102mRh with a half-life of 2.9 years), or about 10 years. These factors make the source unattractive and no large-scale extraction has been attempted.
=== In microalgal biofilms === EPS is found in the matrix of other microbial biofilms such as microalgal biofilms. The formation of biofilm and structure of EPS share a lot of similarities with bacterial ones. The formation of biofilm starts with reversible absorption of floating cells to the surface. Followed by production of EPS, the adsorption will get irreversible. EPS will colonize the cells at the surface with hydrogen bonding. Replication of early colonizers will be facilitated by the presence of organic molecules in the matrix which will provide nutrients to the algal cells. As the colonizers are reproducing, the biofilm grows and becomes a 3-dimensional structure. Microalgal biofilms consist of 90% EPS and 10% algal cells. Algal EPS has similar components to the bacterial one; it is made up of proteins, phospholipids, polysaccharides, nucleic acids, humic substances, uronic acids and some functional groups, such as phosphoric, carboxylic, hydroxyl and amino groups. Algal cells consume EPS as their source of energy and carbon. Furthermore, EPS protects them from dehydration and reinforces the adhesion of the cells to the surface. In algal biofilms, EPS has two sub-categories; soluble EPS (sEPS) and the bounded EPS (bEPS) with former being distributed in the medium and the latter being attached to the algal cells. Bounded EPS can be further subdivided to tightly bounded EPS (TB-EPS) and loosely bounded EPS (LB-EPS). Several factors contribute to the composition of EPS including species, substrate type, nutrient availability, temperature, pH and light intensity.
March 26 Nicolás Maduro and his wife Cilia Flores appear in a New York federal court for their latest hearing, faced with charges of narcoterrorism and weapons offenses. Treasury Secretary Bessent announces that Trump's signature will appear on U.S. paper currency, the first time a sitting president's signature will appear instead of the Treasurer and Secretary of the Treasury. March 27 A House Ethics Committee panel finds that Florida Democratic Representative Sheila Cherfilus-McCormick committed ethics violations in misappropriating federal disaster money for her re-election campaign. A federal appeals court overturns a $16.1 billion judgment against Argentina over their nationalization of oil firm YPF. March 28 Protests against Donald Trump: The third No Kings protests are held in all 50 U.S. states against the policies of Trump and his administration including the Iran war, ICE operations, and the January shootings of Renée Good and Alex Pretti. In the NCAA Tournament, the Arizona Wildcats reach the Final Four for the first time since 2001. Additionally, Illinois reaches the Final Four for the first time since 2005. 3,500 U.S. troops arrive in the Middle East with the USS Tripoli (LHA-7), as strikes between Israel and Iran continue. March 30 – Trump and his son Eric unveil the plans for Trump's presidential library in Miami, Florida, at the Miami Dade College campus. Trump plans for the library to also be a hotel. March 31 AAA reports the average price of gas in the United States has risen to $4 a gallon for the first time since 2022.
=== Francium perchlorate === Francium perchlorate is produced by the reaction of francium chloride and sodium perchlorate. The francium perchlorate coprecipitates with caesium perchlorate. This coprecipitation can be used to isolate francium, by adapting the radiocaesium coprecipitation method of Lawrence E. Glendenin and C. M. Nelson. However, this method is unreliable in separating thallium, which also coprecipitates with caesium. Francium perchlorate's entropy is expected to be 42.7 e.u (178.7 J mol−1 K−1).
Sources: en.wikipedia.org
The predecessor to Burger King was founded in 1953 in Jacksonville, Florida, as Insta-Burger King. After visiting the McDonald brothers' original store location in San Bernardino, California, the founders and owners (Keith G. Cramer and his wife's uncle Matthew Burns), who had purchased the rights to two pieces of equipment called "Insta-machines", opened their first restaurants. Their production model was based on one of the machines they had acquired, an oven called the "Insta-Broiler". This strategy proved so successful that they later required all their franchises to use the device. After the company faltered in 1959, it was purchased by its Miami, Florida, franchisees, James McLamore and David R. Edgerton. They initiated a corporate restructuring of the chain, first renaming the company Burger King. They ran the company as an independent entity for eight years (eventually expanding to over 250 locations in the United States), before selling it to the Pillsbury Company in 1967. Pillsbury's management tried several times to restructure Burger King during the late 1970s and the early 1980s. The most prominent change came in 1978 when Burger King hired McDonald's executive Donald N. Smith to help revamp the company. In a plan called "Operation Phoenix", Smith restructured corporate business practices at all levels of the company. Changes included updated franchise agreements, a broader menu and new standardized restaurant designs. Smith left Burger King for PepsiCo in 1980 shortly before a system-wide decline in sales.
=== Chronic pain === Chronic pain continues to be regarded as the core characteristic of fibromyalgia. According to the NHS, widespread pain is a major symptom, which could feel like an ache, a burning sensation, or a sharp, stabbing pain. Patients are also susceptible to pain, and the slightest touch can cause pain. Pain also tends to linger for a longer period when a patient experiences it. The pain associated with fibromyalgia is often a constant dull ache that has lasted for at least three months, occurring on both sides of the body and above and below the waist. Pain in fibromyalgia may include contributions from central pain, peripheral musculoskeletal pain generators, neuropathic pain, and other pathways. Men may be affected by FM pain differently to women.
Countercurrent Chromatography is a method of separation, that is based on the differential partitioning of analytes between two immiscible liquids using countercurrent or cocurrent flow. Evolving from Craig's Countercurrent Distribution (CCD), the most widely used term and abbreviation is CounterCurrent Chromatography (CCC), in particular when using hydrodynamic CCC instruments. The term partition chromatography is largely a synonymous and predominantly used for hydrostatic CCC instruments.
Cohn (1993), assistant secretary for strategy, planning, analysis & risk of the United States Department of Homeland Security Amit Bose (1994), acting administrator of the Federal Railroad Administration Karthik Ramanathan (1994), acting assistant secretary of the treasury for financial markets Frank Scaturro (1994), lawyer, public advocate who spearheaded the restoration of Grant's Tomb; Republican candidate for New York's 4th congressional district Radhika Fox (1995), acting assistant administrator for water of the United States Environmental Protection Agency Beto O'Rourke (1995), U.S. congressman for Texas's 16th congressional district and candidate in the 2020 United States presidential election Rebekah Gee (1997), secretary of the Louisiana Department of Health, daughter of Ohio State University president E. Gordon Gee Jay Carson (1999), executive director of C40 Cities Climate Leadership Group; former press secretary for Hillary Clinton and Howard Dean's presidential campaigns John Ray Clemmons (1999), member of the Tennessee House of Representatives from the 55th district George Demos (1999), former U.S.
=== Wound healing === Vascularization is crucial for wound healing, as it provides oxygen and nutrients necessary for tissue repair. Angiogenesis temporarily increases vascular density around the wound, aiding the healing process. Vascular endothelial growth factor (VEGF) is a key pro-angiogenic factor in this process, stimulating both vasculogenesis and angiogenesis in the skin. Impaired angiogenesis can result in delayed wound healing, as seen in conditions such as diabetes, where chronic wounds often exhibit reduced levels of active VEGF. Therapeutic stimulation of angiogenesis is being explored to speed up healing, especially in persistent wounds.
Sources: en.wikipedia.org
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.
Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.
No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.